Objectives: The Human papillomavirus (HPV) vaccine is a cornerstone of cancer prevention, yet uptake remains suboptimal in many countries. This study analyzed the factors influencing HPV vaccine acceptance among adults, including a focused analysis of parental behaviors. Methods: Data were collected through a web-based survey using a questionnaire. We performed univariable analysis and three logistic regression analyses to investigate the determinants in the overall sample and among parents. Results: A total of 1821 participants were surveyed. HPV vaccination uptake was low, with only 6.9% of the total sample and 7.6% of young adults (18–35 yo) vaccinated. Among parents, 47.9% had vaccinated children aged 12–17, and 21.1% those aged 18 and over. Higher health literacy was associated with positive attitudes (OR 2.03, 95% CI 1.48–2.79), while receiving information from pediatricians or gynecologists was linked to children’s vaccination status (OR 7.30, 95% CI 2.29–23.31) and parents’ intentions for future HPV vaccination (OR 5.86, 95% CI 1.85–18.50). Adequate knowledge emerged as a strong predictor of positive attitudes (OR 6.50, 95% CI 4.91–8.61) and parents’ intentions (OR 4.89, 95% CI 2.21–10.84). Vaccination status was a key factor influencing parental decisions and overall vaccine acceptance. Conclusions: These findings highlight the critical role of health professionals and the need for targeted communication to address persistent knowledge gaps and promote HPV vaccine confidence within general population.

A cross-sectional study to understand HPV Vaccine hesitancy and influencing factors in Italian adults / Riccio, Marianna; Massimi, Azzurra; Renzi, Erika; Innocenzio, Michele; Siliquini, Roberta; Bert, Fabrizio; Odone, Anna; Marzuillo, Carolina; Villari, Paolo; De Vito, Corrado. - In: VACCINES. - ISSN 2076-393X. - 13:6(2025), pp. 1-19. [10.3390/vaccines13060599]

A cross-sectional study to understand HPV Vaccine hesitancy and influencing factors in Italian adults

Riccio, Marianna
;
Massimi, Azzurra
Co-primo
;
Renzi, Erika;Innocenzio, Michele;Marzuillo, Carolina;Villari, Paolo;De Vito, Corrado
2025

Abstract

Objectives: The Human papillomavirus (HPV) vaccine is a cornerstone of cancer prevention, yet uptake remains suboptimal in many countries. This study analyzed the factors influencing HPV vaccine acceptance among adults, including a focused analysis of parental behaviors. Methods: Data were collected through a web-based survey using a questionnaire. We performed univariable analysis and three logistic regression analyses to investigate the determinants in the overall sample and among parents. Results: A total of 1821 participants were surveyed. HPV vaccination uptake was low, with only 6.9% of the total sample and 7.6% of young adults (18–35 yo) vaccinated. Among parents, 47.9% had vaccinated children aged 12–17, and 21.1% those aged 18 and over. Higher health literacy was associated with positive attitudes (OR 2.03, 95% CI 1.48–2.79), while receiving information from pediatricians or gynecologists was linked to children’s vaccination status (OR 7.30, 95% CI 2.29–23.31) and parents’ intentions for future HPV vaccination (OR 5.86, 95% CI 1.85–18.50). Adequate knowledge emerged as a strong predictor of positive attitudes (OR 6.50, 95% CI 4.91–8.61) and parents’ intentions (OR 4.89, 95% CI 2.21–10.84). Vaccination status was a key factor influencing parental decisions and overall vaccine acceptance. Conclusions: These findings highlight the critical role of health professionals and the need for targeted communication to address persistent knowledge gaps and promote HPV vaccine confidence within general population.
2025
human papillomavirus; vaccine hesitancy; italy; survey
01 Pubblicazione su rivista::01a Articolo in rivista
A cross-sectional study to understand HPV Vaccine hesitancy and influencing factors in Italian adults / Riccio, Marianna; Massimi, Azzurra; Renzi, Erika; Innocenzio, Michele; Siliquini, Roberta; Bert, Fabrizio; Odone, Anna; Marzuillo, Carolina; Villari, Paolo; De Vito, Corrado. - In: VACCINES. - ISSN 2076-393X. - 13:6(2025), pp. 1-19. [10.3390/vaccines13060599]
File allegati a questo prodotto
File Dimensione Formato  
Riccio_Cross-sectional_2025.pdf

accesso aperto

Note: Riccio_2025
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 301.36 kB
Formato Adobe PDF
301.36 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1752988
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact